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Objectives: We investigated the molecular epidemiology of uropathogenic Escherichia coli (UPEC) from a tertiary
care hospital in Riyadh, Saudi Arabia, revealing, for the first time, the population structure of UPEC in the region.
Methods: A total of 202 UPEC isolates were recovered from hospital and community patients with urinary tract
infection in December 2012 and January 2013. Strains were characterized by MLST, antibiotic susceptibility deter-
mination and virulence gene detection.
Results: The most common lineages were ST131 (17.3%), ST73 (11.4%), ST38 (7.4%), ST69 (7.4%), ST10 (6.4%),
ST127 (5.9%), ST95 (5.4%), ST12 (3.5%), ST998 (3.5%) and ST405 (3%). ST131 and ST405 isolates were signifi-
cantly associated with high levels of antibiotic resistance (60% of ST131 carried CTX-M-14 or CTX-M-15 and
66.7% of ST405 isolates carried CTX-M-15). ST131, CTX-M-15-positive isolates were predominantly of the
fimH30/clade C group, resistant to fluoroquinolones; members of this sub-group were more likely to carry a
high number of genes encoding selected virulence determinants. The relatively high proportion of ST38 was
notable and four of these isolates harboured aggR.
Conclusions: Our findings highlight the presence of MDR, CTX-M-positive ST38, ST131 and ST405 UPEC in Saudi
Arabia. The high proportion of isolates with CTX-M is a particular concern. We suggest that ST38 UPEC warrant
further study.
Introduction
Urinary tract infection (UTI), one of the most common infections in
humans, is predominantly caused by uropathogenic Escherichia coli
(UPEC). The population structure and antibiotic susceptibility of
leading UPEC clones and the importance of key virulence-associated
traits and distinctive O antigens in pathogenesis have been widely
studied.1,2
Globally disseminated MDR strains of O25b:H4-ST131 E. coli
(ST131) are responsible for a high proportion of UTI and blood-
stream infections.3 The most prevalent ST131 sub-clone is asso-
ciated with widespread dissemination of the CTX-M-15 ESBL
enzyme with co-resistance to fluoroquinolones and carriage of
the H30 variant of the type 1 fimbrial adhesin gene, fimH.4 This
sub-clone is known as H30-Rx, or clade C.3,5 Although UPEC are
extraintestinal E. coli (ExPEC) pathogens, some strains carry viru-
lence properties more characteristic of enteroaggregative E. coli
(EAEC).6,7
To our knowledge, there have been no robust epidemiological
studies of UPEC in Saudi Arabia, a key member state of the Middle
East and the Gulf Cooperation Council. A recent systematic review
shows a growing problem of antibiotic-resistant Gram-negative
bacteria in this region, but the roots of the problem have never
been fully investigated.8 Accordingly, we have examined the
population structure of UPEC at a tertiary care hospital in Saudi
Arabia and our findings may help inform infection control to
prevent the spread of MDR strains from the region.
Materials and methods
Bacterial isolates
A total of 202 non-duplicate, consecutive isolates of E. coli from patients
with clinically confirmed UTI were obtained from King Abdulaziz Medical
City (KAMC) in Riyadh, Saudi Arabia. This 1000 bed tertiary healthcare cen-
tre serves a population of 500000 of the Saudi National Guard soldiers and
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their dependants. Prospectively collected isolates from inpatients and out-
patients (December 2012 to January 2013) were not selected on the basis
of any resistance profile. Identification was performed using the Vitek II XL
(bioMérieux, France) with the Gram Negative Susceptibility Card, AST-GN26.
Isolates were maintained on Sheep Blood Agar (Saudi Prepared Media
Laboratory) and Transwabsw in Amies transport medium (Medical Wire
and Equipment, England) were used to transport the isolates to the UK,
following international guidelines (UN 2814). Clinical and demographic
parameters (patient age, gender, specimen type and geographical origin)
were examined anonymously.
Molecular typing
Pure cultures on Columbia Agar (Oxoid), incubated at 378C for 18 h, were
used for DNA extraction with the PrepMan Ultra kit (Applied Biosystems,
USA). MLST was carried out using the Achtman scheme (http://mlst.
warwick.ac.uk/mlst/dbs/Ecoli).9 fimH typing was performed to investigate
possible sub-typing within STs.4 Molecular serotyping was performed to
detect 14 serogroups associated with UTI.10 Additional O typing was per-
formed on all ST131 strains to detect the O16-ST131 and O25b-ST131
clades.5
Virulence genotyping
Virulence factor (VF) carriage was assessed by PCR.1 The virulence score
equalled the sum of positive VFs for each isolate. All ST38 isolates were
screened for the presence of the EAEC transport regulator gene (aggR)6
in 25 mL reactions containing 12.5 mL of 2× BioMix Red (Bioline USA Inc.),
1 mL of each primer (10 pmol/mL) and 1 mL of chromosomal DNA.
Amplification proceeded at 948C for 4 min, 30 cycles at 948C for 30 s,
588C for 30 s and 728C for 1 min, with a final extension at 728C
for 5 min. PCR products were visualized with UV transillumination in
agarose gels.
Antimicrobial susceptibility profiling
Susceptibility testing was performed using the Vitek II XL with AST-GN26
cards. Resistance scores were calculated by dividing the number of anti-
biotics to which an isolate was resistant by the total number of antibiotics
being studied. Selected isolates were screened for the presence of
b-lactamase genes blaTEM, blaSHV, blaCTX-M, blaNDM-1 and blaOXA-1/48.
11 – 14
Strains from STs associated with quinolone resistance were examined
for mutations in quinolone resistance-determining regions of gyrA and
parC.15
Statistical analysis
Fisher’s exact test was conducted with a threshold for statistical
significance of P,0.05.
Results and discussion
Molecular typing reveals the population structure
of UPEC in Riyadh
The majority of examined isolates (87.1%) were from females and
patient age ranged from ,2 months to 87 years (mean age
40 years); 141 isolates (69.2%) were considered to be community
acquired, being recovered from outpatients with a clinical diagno-
sis of uncomplicated UTI.
MLST resolved 51 unique STs. The most common were ST131
(n¼35; 17.3% of isolates), ST73 (23; 11.4%), ST38 (15; 7.4%),
ST69 (15; 7.4%), ST10 (13; 6.4%), ST127 (12; 5.9%) and ST95
(11; 5.4%), which accounted for 61% of the isolates (Table S1, avail-
able as Supplementary data at JAC Online). On the whole, this
reflects the global dominance of a small number of lineages, usually
including ST131.3,15,16 Members of ST131 were predominantly com-
munity isolates (69%; 24/35 isolates) and the majority (77%; 27/35)
belonged to O25b-ST131 fimH30/clade C3; 20% (7/35) were from
O16-ST131 fimH41 and one was O25b-ST131 fimH22.5,17
ST38 isolates have not been widely reported as predominant
members in collections of UPEC, but it has been suggested that
this group is evolving and is becoming more commonly seen in
UTI.6,18 The diversity in VF carriage and susceptibility profiles
observed here (see below) suggests that several ST38 strains are
circulating in the population in Riyadh.
High levels of antibiotic resistance are present
in the KAMC isolates
STs varied considerably in antibiotic susceptibility from the most sus-
ceptible, ST73 (resistance score median 0.1 and range 0.0–0.3), to
the most resistant, ST131 (median 0.5 and range 0.2–0.7). Overall,
35% of the isolates exhibited an ESBL phenotype (Table 1). Similar
levels of ESBL-producing UPEC have been reported in some countries
in the Asia-Pacific region and the Middle East.8,19 However, in the EU
and North America, reported rates are often close to, or below,
5%.15,16 Many ESBL producers were co-resistant to non-b-lactam
antibiotics, including ciprofloxacin and trimethoprim/sulfamethoxa-
zole, which is a cause for concern, as this will lead to limited treat-
ment options for UPEC infection. The high prevalence of ESBLs in
Riyadh is already driving high levels of carbapenem prescriptions in
the community (S. M. Al Johani, KAMC), which is a genuine threat to
the future clinical utility of these antibiotics.
ST131 (P≤0.002) and ST405 (P≤0.02) were significantly asso-
ciated with ESBL production (Table 1). Although there was not a
significant association, 5/7 ST998 isolates were also ESBL produ-
cers. This ST has not been widely reported in UTI, but may be an
important resistant clone in Riyadh. Detection of CTX-M-like genes
was conducted to investigate the mechanism of ESBL production
in ST38, ST131 and ST405, as these key clones demonstrated ele-
vated levels of ESBL production. In line with previous reports,
CTX-M carriage was most common in ST131 isolates (n¼21
60% of ST131) that were positive for CTX-M-14 (eight isolates
belonging to O25b-ST131 fimH30) and CTX-M-15 (nine isolates
belonging to O25b-ST131 fimH30 and two isolates from
O16-ST131 fimH41).2,5 One O25b-ST131 fimH30 isolate carried
both CTX-M-14 and CTX-M-15. The ESBL phenotype of ST38 and
ST405 isolates was predominantly mediated by CTX-M-15 (5/6
and 4/5 isolates, respectively). Little is known about the spread
of CTX-M-type ESBLs among EAEC strains,6 but the surprisingly
high detection rate for ST38 UPEC in our study and the suggested
emergence of ExPEC with UPEC and EAEC characteristics indicates
that increased surveillance for this clone is warranted, so that we
can fully understand the significance of these pathotypes in UTI. A
total of 10 isolates from O25b-ST131 fimH30 and 5 isolates of
ST38 were positive for OXA-1-like determinants.
Resistance to fluoroquinolones was significantly associated
with ST131, ST405 and ST410 (Table 1). The O25b-ST131
fimH30/clade C isolates were significantly more likely to be
ciprofloxacin-resistant (P≤0.0008) than members of O16-ST131
fimH41. Most of the ciprofloxacin-resistant isolates had multiple
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ST131 35 33 2 33 27 20 0 20 20 14 21 9 4 25 32 4 23 0.43, 0.5 (0.2–0.7)
P value 0.007 — 0.007 0.01 0.006 — 0.003 0.001 0.0008 0.002 0.014 — 0.0001 0.0001 — —
ST73 23 15 1 15 7 0 0 0 0 0 0 0 0 0 0 0 9 0.11, 0.1 (0.0–0.3)
P value — — — — — — — — — — — — — — — —
ST38 15 15 4 15 8 6 2 6 6 3 6 1 2 3 8 3 8 0.33, 0.3 (0.1–0.7)
P value 0.02 — 0.02 — — — — — — — — — — — 0.02 —
ST69 15 14 2 14 4 4 2 4 3 1 4 1 0 1 2 0 12 0.23, 0.2 (0.1–0.7)
P value — — — — — — — — — — — — — — — 0.03
ST10 13 8 1 8 3 3 1 3 2 0 3 0 0 2 2 0 7 0.17, 0.2 (0.0–0.5)
P value — — — — — — — — — — — — — — — —
ST127 12 7 0 7 3 1 0 1 1 0 1 0 0 0 0 0 2 0.1, 0.1 (0.0–0.4)
P value — — — — — — — — — — — — — — —
ST95 11 5 1 5 2 2 1 2 1 2 2 0 0 1 3 0 3 0.14, 0.1 (0.0–0.5)
P value — — — — — — — — — — — — — — — —
ST12 7 3 0 3 1 1 0 1 1 0 1 1 0 1 4 0 4 0.16, 0.2 (0.0–0.5)
P value — — — — — — — — — — — — — — — —
ST998 7 6 2 6 5 5 2 5 5 2 5 3 0 0 0 0 3 0.38, 0.4 (0.0–0.7)
P value — — — — 0.02 — 0.05 0.04 — — 0.017 — — — — —
ST405 6 6 0 6 6 5 4 5 5 4 5 0 0 6 6 0 6 0.53, 0.6 (0.4–0.6)
P value — — — 0.04 0.005 0.001 0.02 0.01 0.009 0.02 — — 0.0008 0.007 — 0.03
ST410 6 6 2 6 2 2 1 2 2 2 2 0 1 5 6 0 4 0.39, 0.2 (0.2–0.8)
P value — — — — — — — — — — — — 0.01 0.007 — —
AMP, ampicillin; AMC, amoxicillin/clavulanic acid; PIP, piperacillin; CEF, cefalotin; CXM, cefuroxime; FOX, cefoxitin; CPD, cefpodoxime; CTX, cefotaxime; CAZ, ceftazidime; AAC,
N-acetyltransferase; ANT, O-adenyltransferase; CIP, ciprofloxacin; NOR, norfloxacin; NIT, nitrofurantoin.
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Table 2. Prevalence of various UPEC-associated VFs within the most commonly detected clonal groups observed in the isolate collection
Category Specific trait
Prevalence (%) of VF by ST (no. of isolates is given in parentheses)
total (n¼202) ST10 (n¼13) ST38 (n¼15) ST69 (n¼15) ST73 (n¼23) ST95 (n¼11) ST127 (n¼12) ST131 (n¼35) ST405 (n¼6)
Adhesion papA 59 (29) 5 (38) 3 (20) 8 (53) 8 (35) 6 (55) 7 (58) 8 (23) 2 (33)
papC 72 (36) 6 (46) 4 (27) 10 (67) 8 (35) 5 (45) 7 (58) 11 (31) 0 (0)
papEF 56 (28) 2 (15) 2 (13) 9 (60) 12 (52) 5 (45) 8 (67) 5 (14) 1 (17)
papGII,III 15 (7) 1 (8) 0 (0) 0 (0) 1 (4) 6 (55) 3 (25) 3 (9) 0 (0)
allele-II 39 (19) 2 (15) 4 (27) 7 (47) 6 (26) 3 (27) 3 (25) 2 (6) 1 (17)
allele-III 42 (21) 5 (38) 3 (20) 2 (13) 3 (13) 3 (27) 4 (33) 10 (29) 1 (17)
sfa/foc DE 34 (17) 1 (8) 2 (13) 2 (13) 3 (13) 5 (45) 2 (17) 8 (23) 1 (17)
afa/draBC 25 (12) 0 (0) 2 (13) 0 (0) 1 (4) 1 (9) 4 (44) 4 (11) 1 (17)
sfaS 22 (11) 0 (0) 0 (0) 1 (7) 2 (9) 4 (36) 3 (25) 5 (14) 1 (17)
Toxins hlyA 14 (7) 0 (0) 1 (7) 0 (0) 3 (13) 4 (36) 2 (17) 0 (0) 0 (0)
cnf1 42 (21) 2 (15) 4 (27) 1 (7) 10 (43) 4 (36) 4 (33) 9 (26) 0 (0)
Siderophore fyuA 154 (76) 8 (62) 13 (87) 11 (73) 19 (83) 4 (36) 9 (75) 30 (86) 6 (100)
iutA 118 (58) 5 (38) 10 (67) 11 (73) 15 (65) 8 (73) 7 (58) 25 (71) 1 (17)
Capsule kpsM II 76 (38) 4 (31) 4 (27) 8 (53) 9 (39) 6 (55) 6 (50) 20 (57) 1 (17)
K1 30 (15) 3 (23) 1 (7) 2 (13) 2 (9) 1 (9) 3 (25) 8 (23) 1 (17)
K5 75 (37) 2 (15) 4 (27) 6 (40) 10 (43) 4 (36) 9 (75) 14 (40) 1 (17)
Miscellaneous cvaC 6 (3) 0 (0) 0 (0) 2 (13) 0 (0) 2 (18) 1 (8) 0 (0) 0 (0)
traT 128 (63) 4 (31) 10 (67) 15 (100) 17 (74) 7 (64) 12 (100) 21 (60) 2 (33)
PAI (malX) 65 (32) 2 (15) 7 (47) 9 (60) 10 (43) 6 (55) 4 (33) 13 (37) 2 (33)
VF score [mean, median (range)] 5, 5 (1–11) 6.2, 5 (2–13) 8.1, 7 (2–14) 7.9, 7 (2–15) 9.2, 10 (2–14) 9.4, 9.5 (5–14) 7.1, 6 (2–13) 4.8, 4 (2–10)
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reported previously.15,17 However, two fluoroquinolone-resistant
isolates from O25b-ST131 fimH30/clade C and ST410 showed
E(153)K mutations in gyrA, which has only been previously
described on a single occasion in Pseudomonas aeruginosa.20
Prevalence of VFs varies widely across ST
STs varied considerably in VF content, from ST405, with the lowest
score (mean 4.8), to ST127, with the highest score (mean 9.4)
(Table 2). Members of ST131 showed a moderate VF score (mean
7.1), which was equivalent to VF carriage across other phylogenetic
group B2 clones (e.g. ST73, ST95 and ST127 in Table S1).
In isolates from ST73, ST95 and ST127, carriage of several VFs
was lower than expected.1,15 These included kpsM II, K1 and PAI
(malX) and the variation may indicate geographical differences in
VF carriage, an interesting observation that warrants further study
(Table 2).
Plasmid-mediated carriage of the EAEC transport regulator
gene, aggR, has been reported as a key feature of emerging
ST38 UPEC from Germany, the Netherlands and the UK.6
Accordingly, ST38 isolates were screened for aggR and 4/15
were positive (Table S3), though we did not examine plasmid car-
riage in these isolates. Overall, ST38 isolates varied in VF carriage
from 2 to 13, with no clear differentiation between VF carriage in
aggR-positive or aggR-negative strains (Table S3). The presence of
aggR may indicate the evolution of a strain possessing both UPEC
and EAEC characteristics and highlights the diverse mechanisms
employed by E. coli to ensure fitness and mediate pathogenicity in
different ecological niches. On-going genome sequence analysis
of some ST38 strains from Riyadh will significantly enhance our
understanding of these organisms.
Conclusions
In conclusion, following the recent report of carbapenem-
resistant NDM-1 and OXA-48 E. coli strains in the Arabian region,8
we now describe the population structure of UPEC from a major
medical centre in Saudi Arabia, revealing the presence of MDR
strains with high virulence potential, including those of ST131.
ST38 strains from the region carry both UPEC and EAEC virulence
determinants and warrant close monitoring.
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